Skip to main content
Premium Trial:

Request an Annual Quote

Roche R&D Group To Use Genedata's Refiner MS Module

NEW YORK (GenomeWeb News) - Genedata said last week that Roche Molecular Medicine Laboratories in Basel, Switzerland, will integrate its Expressionist Refiner MS module within its proteomics analysis pipeline.

 
Refiner MS automatically assesses and pre-processes mass spectrometry-based proteomics and metabolomics data.
 
Genedata CEO Othmar Pfannes told GenomeWeb Daily News sister publication BioInform that the agreement builds on a collaboration that the companies began several years ago to validate the throughput of Refiner MS.
 
He said that the software is designed to handle MS data from clinical studies involving several thousand patients, and that Roche is one of several customers that validated the software in smaller studies involving 30 to 40 patients.
 
Pfannes said that pre-processing of MS data is particularly important for large-scale proteomics and metabolomics studies because the mis-identification of just a single peak “could lead to a lot of wrong comparisons.”
 
He said that a number of Genedata’s customers are moving toward using mass spec in large-scale clinical studies, and noted that “It looks like this is going to be a major success for us over the next six months or so.”

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.